|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 4.160 USD | +1.96% |
|
+0.24% | +45.96% |
| 09-20 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ORMP | Delayed | |
CBOE
| ORMP | Real-time | |
|
Börse Stuttgart
| OJU1 | Delayed | |
|
TEL AVIV STOCK EXCHANGE
| ORMP | Delayed | |
|
Tradegate
| OJU1 | Real-time | |
|
Deutsche Boerse AG
| OJU1 | Delayed | |
|
Boerse Muenchen
| OJU1 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 4.48 | 5.34 | 5.03 |
| Spread/Res. | -7.14% | -22.10% | -17.30% |
| Spread/Supp. | +2.46% | +15.56% | +12.13% |
| Support | 4.06 | 3.6 | 3.71 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ORMP Stock
- Charts Oramed Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
